Citius Pharmaceuticals Inc
General ticker "CTXR" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $526.0M
Citius Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -30.7%.
Estimated limits based on current volatility of 6.4%: low 2.44$, high 2.78$
Factors to consider:
- Earnings expected soon, date: nan
- Current price 64.3% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [10.34$, 25.42$]
- 2024-09-29 to 2025-09-29 estimated range: [8.16$, 20.23$]
Financial Metrics affecting the CTXR estimates:
- Negative: Non-GAAP EPS, $ of -0.24 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -19.19 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -2.94 <= -0.39
Short-term CTXR quotes
Long-term CTXR plot with estimates
Financial data
YTD | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $23.53MM | $33.32MM | $36.73MM |
Operating Income | $-23.53MM | $-33.32MM | $-36.73MM |
Non-Operating Income | $0.48MM | $0.25MM | $4.77MM |
Interest Expense | $0.01MM | $0.00MM | $0.00MM |
R&D Expense | $12.24MM | $17.66MM | $14.82MM |
Income(Loss) | $-23.05MM | $-33.06MM | $-31.97MM |
Taxes | $0.00MM | $0.58MM | $0.58MM |
Profit(Loss) | $-23.05MM | $-33.64MM | $-32.54MM |
Stockholders Equity | $132.18MM | $102.83MM | $90.83MM |
Assets | $142.43MM | $114.00MM | $103.61MM |
Operating Cash Flow | $-24.25MM | $-28.36MM | $-29.06MM |
Capital expenditure | $40.01MM | $0.00MM | $0.00MM |
Investing Cash Flow | $-40.01MM | $0.00MM | $0.00MM |
Financing Cash Flow | $120.47MM | $0.00MM | $13.83MM |
Earnings Per Share* | $-0.21 | $-0.23 | $-0.23 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.